Social Capital Suvretta Holdings Corp. III
Status: Closed Deal
U=S
| IPO Proceeds, $M | $250.00M |
|---|---|
| IPO Date | Jun 30, 2021 |
| CEO | Chamath Palihapitiya |
| Left Lead | Morgan Stanley |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | ProKidney |
| Deal Announced | Jan 18, 2022 |
| Deal Size, $M | $1,835.00M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Jul 11, 2022 |
| Amendment Vote | TBD |
| Closing Date | Jul 11, 2022 |
Formerly DNAC
PROK
| Price | $1.08 |
|---|---|
| Last closing price | $1.03 |
| H/L, today | $0.96 / $1.11 |
| H/L, 52-week | $1.45 / $14.19 |
| Volume, today | 764,704 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.